Human ion-exchanger proteins

• US 7,057,029 B2
• Filed: 07/07/2004
• Issued: 06/06/2006
• Est. Priority Date: 09/27/2000
• Status: Expired due to Fees

• Current Assignee: Lexicon Genetics, Incorporated
• Original Assignee: Lexicon Genetics, Incorporated
• Inventors: Friddle, Carl Johan, Gerhardt, Brenda
• Primary Examiner(s): Li, Ruixiang
• Application Number:
  US10/886,518
• Publication Number:
  US 20050059050A1
• Time in Patent Office: 699 Days
• Field of Search: 530/350
• US Class Current: 536/23.5
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: C07K 14/705 Receptors; Cell surface antigens; Cell surface determinants tumour specific antigens C07K14/4748

Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

Claims

1. An isolated polypeptide comprising an amino acid sequence drawn selected from the group consisting of SEQ ID NOS:

2, 4 and 6.